Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.
Let's get started...
Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.
Let's get started...
| Role | Insider | Date | Transaction | Value | Shares |
|---|---|---|---|---|---|
| CFO | CAREY STEPHEN P. | Aug 31, 2026 | Sell | $207.48K | 2,850 |
| CEO | Lalwani Nikhil | Aug 25, 2026 | Sell | $401.22K | 5,400 |
| SR. VP, GENERAL COUNSEL & SEC. | Cook Meredith | Aug 13, 2026 | Sell | $37.74K | 500 |
| SVP, GENERICS | Gutwerg Ori | Aug 10, 2026 | Sell | $243.47K | 3,162 |
| CFO | CAREY STEPHEN P. | Jul 29, 2026 | Sell | $231.88K | 2,850 |
| SR. VP, GENERAL COUNSEL & SEC. | Cook Meredith | Jul 13, 2026 | Sell | $40.92K | 500 |
| CFO | CAREY STEPHEN P. | Jul 2, 2026 | Sell | $284.92K | 3,313 |
| CFO | CAREY STEPHEN P. | Jun 29, 2026 | Sell | $239.74K | 2,850 |
| SR. VP, GENERAL COUNSEL & SEC. | Cook Meredith | Jun 12, 2026 | Sell | $41.02K | 500 |
| Director | HAUGHEY THOMAS | Jun 8, 2026 | Sell | $161.76K | 2,000 |
| CFO | CAREY STEPHEN P. | Jun 5, 2026 | Sell | $264.96K | 3,312 |
| SR. VP, GENERAL COUNSEL & SEC. | Cook Meredith | May 13, 2026 | Sell | $39.08K | 500 |
| Director | Walsh Patrick D | May 13, 2026 | Sell | $806.3K | 10,000 |
| SVP, HEAD - ESTABLISHED BRANDS | Rowland Thomas Andrew | May 12, 2026 | Sell | $36.36K | 459 |
| SVP, GENERICS | Gutwerg Ori | May 12, 2026 | Sell | $220.37K | 2,772 |
| CEO | Lalwani Nikhil | May 11, 2026 | Sell | $4.27M | 55,000 |
| Director | Walsh Patrick D | May 11, 2026 | Sell | $320.82K | 3,973 |
| SR. VP, GENERAL COUNSEL & SEC. | Cook Meredith | Apr 13, 2026 | Sell | $38.98K | 500 |
| HEAD OF RARE DISEASE | Mutz Christopher | Mar 13, 2026 | Sell | $226.53K | 3,162 |
| SR. VP, GENERAL COUNSEL & SEC. | Cook Meredith | Mar 13, 2026 | Sell | $36.31K | 500 |
| SVP, HEAD - ESTABLISHED BRANDS | Rowland Thomas Andrew | Mar 11, 2026 | Sell | $357.47K | 4,772 |
| SVP, CHIEF HR OFFICER | Davis Krista | Mar 9, 2026 | Sell | $377.1K | 5,087 |
| HEAD OF RARE DISEASE | Mutz Christopher | Mar 9, 2026 | Sell | $267.2K | 3,602 |
| HEAD OF RARE DISEASE | Mutz Christopher | Mar 6, 2026 | Sell | $157.42K | 2,121 |
| SVP, CHIEF HR OFFICER | Davis Krista | Mar 6, 2026 | Sell | $111.38K | 1,485 |
Open-market purchases and sales reported on SEC form 4 over the last 10years. Awards, option exercises, gifts and other non-market form 4 activity are excluded. Chart markers group a day's filings by direction; the table lists each filing.
